Fig. 2From: Quality of life in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: a systematic review and meta-analysisQuality assessment of the eligible studies in risk-of-bias graph (A) and risk-of-bias summary (B)Back to article page